Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
2014 Mar 21
osteomalacia
10-(3-Dimethylaminopropyliden)thioxanthen
18)15-11(16)7-2-1-6(13)5-8(7)14/h1-5H
InChi: InChI=1S/C17H21N3O/c1-19(2)16-10-8-13(9-11-16)14-6-5-7-15(12-14)18-17(21)20(3)4/h5-12H
Erlotinib U-03012 2014 Mar 21Erlotinib is an epidermal growth factor receptor inhibitor (EGFR inhibitor). Erlotinib HCl was approved. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the
US$ 185.50
US$ 255.00
US$ 150.00
US$ 140.00
US$ 280.00
US$ 101.49